Brief: Palisade Bio Q3 EPS USD -0.49
10/11/2023 13:05
Nov 10 (Reuters) - Palisade Bio Q3 operating expenses USD 3.778 million. * Q3 operating income USD -3.778 million * Q3 net income USD -3.596 million
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing